Regulatory Environment and Approvals in Cell and Gene Therapy Products Between Japan, the USA, and the EU

被引：0
|
作者：
Yuya Sato
Shunsuke Ono
机构：
[1] The University of Tokyo,Laboratory of Pharmaceutical Regulatory Science, Graduate School of Pharmaceutical Sciences
来源：
Therapeutic Innovation & Regulatory Science | 2023年 / 57卷
关键词：
Cell and gene therapy; Regulatory approval; Regulatory environment; Market entry; Clinical evidence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：227 / 237
页数：10
相关论文
共 50 条
  • [41] REGULATORY CONSIDERATIONS FOR GENE-THERAPY STRATEGIES AND PRODUCTS
    WIVEL, NA
    TRENDS IN BIOTECHNOLOGY, 1993, 11 (05) : 189 - 191
  • [42] Impacts of the regulatory environment for gene editing on delivering beneficial products
    Jenkins, Daniel
    Dobert, Raymond
    Atanassova, Ana
    Pavely, Chloe
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT, 2021, 57 (04) : 609 - 626
  • [43] Impacts of the regulatory environment for gene editing on delivering beneficial products
    Daniel Jenkins
    Raymond Dobert
    Ana Atanassova
    Chloe Pavely
    In Vitro Cellular & Developmental Biology - Plant, 2021, 57 : 609 - 626
  • [44] To: Aastrom for: Cell therapy, gene therapy products
    不详
    BIOTECHNOLOGY LAW REPORT, 1999, 18 (04) : 344 - 344
  • [45] Regulatory hurdles for CART-cell therapy in Japan
    Nagai, Sumimasa
    LANCET HAEMATOLOGY, 2021, 8 (10): : E686 - E687
  • [46] Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (04):
  • [47] Influence of technical trade measures of label of EU, USA and Japan on Chinese alcoholic products export
    Liu, B., 2013, South China University of Technology, Guangzhou, 510640, China (29)
  • [48] Difference of environment behind research and clinical practice between USA and Japan
    Komiya, Takefumi
    Chaaya, Gerard
    Deshotels, Leigh
    Wang, Andy
    JOURNAL OF THORACIC DISEASE, 2020, 12 (07) : 3804 - 3808
  • [49] GENE THERAPY PRODUCTS - MARKET ACCESS SITUATION IN EU AND IN SLOVAKIA
    Marusakova, E.
    Vulganova, M.
    VALUE IN HEALTH, 2018, 21 : S347 - S347
  • [50] FINDING OUT THE REGULATORY REQUIREMENTS FOR THE DEVELOPMENT OF GENE AND CELL THERAPY PRODUCTS WITH THE EUROGCT RESEARCH PATHWAYS
    Delage, Auxane
    Gilbert, Luc-Sylvain
    Kuo, Hsin-Yu
    Lorigan, Jennifer
    Blackburn, Clare
    Couturier, Anna
    Waite, Amanda
    Mahalatchimy, Aurelie
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 684 - 685
12345